Sunitinib | High-Quality Pharmaceutical Reference Standard
Sunitinib is a multi-targeted tyrosine kinase inhibitor used in the treatment of renal cell carcinoma, gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors. It works by inhibiting receptor tyrosine kinases involved in tumor growth and angiogenesis. Sunitinib API is produced under GMP standards and is suitable for oral solid dosage formulations, including tablets.
Sunitinib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 8
